探花合集 Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan
SOMERSET, N.J. 鈥 December 10, 2020 鈥 探花合集, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakaya 鈥淣ick鈥 Matsumaru as General Manager of its new clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
Reporting to Roel de Nobel, 探花合集鈥檚 Vice President of Operations for Europe and Asia-Pacific, Mr. Matsumaru joins the company from SymBio Pharmaceuticals Ltd, where he held the role of Senior Director Supply Chain & Quality Assurance. Prior to this, he spent four years in vice president, executive officer and head of operations posts with AstraZeneca, and seven years in Japan-based supply chain management with Johnson & Johnson and Janssen. He holds a bachelor鈥檚 degree in sociology from Keio University in Tokyo.
鈥淲e are pleased to welcome Nick to head our clinical supplies business at our new facility in Shiga, which in partnership with our existing Japanese facility in Kakegawa, will provide flexible clinical supply solutions to customers in Japan and global biotech and pharmaceutical companies,鈥 commented Mr. de Nobel. He added, 鈥淣ick brings a great deal of experience, and will play an important role in the ongoing expansion of 探花合集鈥檚 Asia-Pacific network and ensuring that customers鈥 clinical trials continue to be well-served across the region, and worldwide.鈥
探花合集 announced it had completed the acquisition of the 60,000-square-foot facility in Shiga from Teva-Takeda Pharmaceuticals in July 2020. The facility is the latest in 探花合集鈥檚 expanding Asia-Pacific clinical supplies network, and alongside the existing Japanese facility in Kakegawa, the company鈥檚 two sites in China and one in Singapore, will offer extensive services including access to primary and secondary packaging capabilities, 探花合集鈥檚 FastChain庐 demand-led supply services, a range of temperature options for storage and distribution, as well as clinical returns and destruction services.
鈥婣BOUT CATALENT CLINICAL SUPPLY SERVICES
探花合集 is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. 探花合集 offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years鈥 experience across thousands of studies in more than 80 countries, 探花合集 has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
ABOUT CATALENT
探花合集 is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. 探花合集 employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com